Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02134951 · ClinicalTrials.gov registry record · Phase 4

Biomarker Assessment of Glutamatergic Target Engagement

A Phase 4 study of Healthy (Controls), sponsored by New York State Psychiatric Institute.

Completed
Registry status
Phase 4
Development phase
65
Enrollment target
3
Study locations

NCT02134951 is a Phase 4 study of Healthy (Controls) that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 65 participants, below the 117-participant average among 16 other Healthy (Controls) trials with a reported enrollment target (44% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02134951, a Phase 4 study of Healthy (Controls), has completed, sponsored by New York State Psychiatric Institute.

COMPLETED
Registry status
Phase 4
Development phase
65 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to assess the relative feasibility of 2 potential functional measures of target engagement (Glx MRS, BOLD fMRI) to systematically assess mGluR 2/3 in drug development for psychotic spectrum disorders.

Conditions Studied

Healthy (Controls)

Interventions

  • DRUG Ketamine
  • DRUG Normal saline

Study Locations (3)

California

  • University of California Davis - Sacramento

Connecticut

  • Yale University - New Haven

New York

  • New York State Psychiatric Institute - New York

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2014-05
Est. Completion 2015-11
Phase Phase 4

Sponsor

New York State Psychiatric Institute

364 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02134951

The ClinicalTrials.gov registry entry for NCT02134951 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 117-participant average among 16 other Healthy (Controls) trials with a reported enrollment target (44% lower). The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy (Controls) appearing as the primary indexed condition, and to 2 interventions - of which Ketamine is the first listed.

NCT02134951 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, Connecticut, New York.

Frequently Asked Questions

What is clinical trial NCT02134951 about?

NCT02134951 is a clinical study titled "Biomarker Assessment of Glutamatergic Target Engagement". The purpose of this study is to assess the relative feasibility of 2 potential functional measures of target engagement (Glx MRS, BOLD fMRI) to systematically assess mGluR 2/3 in drug development for psychotic spectrum disorders.

What is the current status of trial NCT02134951?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 65 participants. The study started on 2014-05. Estimated completion is 2015-11.

What conditions does trial NCT02134951 study?

This clinical trial studies the following conditions: Healthy (Controls).

What interventions are being tested in trial NCT02134951?

The interventions under investigation include: Ketamine (DRUG), Normal saline (DRUG).

Who is sponsoring clinical trial NCT02134951?

This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02134951 being conducted?

This trial has 3 study locations across California, Connecticut, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy (Controls)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy (Controls)

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.